Peanut and soy share several characteristics that are relevant to allergy. First, as legumes, they are phylogenetically and antigenically (1, 2) similar to each other and to other beans. Second, they are common sources of protein in the food supply; therefore, exposure to them is widespread. Third, they are an exceedingly common cause of food allergy (3±7). While these two food allergens have much in common, the clinical manifestations of allergy to peanut and soy are generally quite distinct. This paper will explore the similarities and differences in the clinical manifestations of peanut and soy allergy, summarize the current understanding of the molecular-immunologic aspects of these allergies, and discuss recent concerns regarding the development of severe allergy to soy in peanutallergic individuals.
Characteristics of peanut allergy
PrevalenceRecent surveys of the general population found the prevalence of peanut allergy to be 0.48% in the UK (7) and 0.6% in the USA (3). Peanut is ubiquitous within the US food supply, with virtually 100% of US children being exposed by the age of 2 years (8). The sensitization rate to peanut in a birth cohort of children on the Isle of Wight, UK, followed to the age of 4 years, was 1%, with half having experienced a clinical reaction to peanut (9). In children with atopic dermatitis undergoing evaluation for food hypersensitivity, 20/113 (18%) (5) and 27/165 (16%) (4) were allergic to peanut.
Clinical manifestationsThe clinical characteristics of peanut allergy have been explored from a variety of vantage points. Studies of peanut-allergic individuals have highlighted the acute and severe nature of the allergy. In our study of 101 children (median age 7.6 years) with acute reactions to peanut (10), reactions occurred soon after ingestion, with 91% experiencing skin symptoms, 45% respiratory symptoms, and 36% gastrointestinal symptoms. In this group, 47% had involvement of two or more organ systems and 20% required treatment with epinephrine for their ®rst reaction. A study of 622 peanut-allergic individuals in the UK (11) also highlighted the severity of reactions because over 50% had moderate to severe reactions with breathing dif®culties or cardiovascular collapse. Severe symptoms were more common in adults than young children.